Yingkun Zhi Selected Research

Indomethacin (Indometacin)

12/2021

Sinomenine increases adenosine A2A receptor and inhibits NF-κB to inhibit arthritis in adjuvant-induced-arthritis rats and fibroblast-like synoviocytes through α7nAChR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingkun Zhi Research Topics

Disease

3	Inflammation (Inflammations) 12/2021 - 01/2020
1	Arthritis (Polyarthritis) 12/2021
1	Rheumatoid Arthritis 12/2021
1	Neuroinflammatory Diseases 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Endotoxemia 01/2020

Drug/Important Bio-Agent (IBA)

2	sinomenineIBA 12/2021 - 01/2021
2	homoorientin (isoorientin)IBA 01/2021 - 01/2020
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 12/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 12/2021
1	Methotrexate (Mexate)FDA LinkGeneric 12/2021
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2021
1	AlkaloidsIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Nicotine FDA Link 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	LipopolysaccharidesIBA 01/2020
1	OccludinIBA 01/2020
1	Glycogen Synthase KinasesIBA 01/2020

Therapy/Procedure

1	Oral Administration 01/2021